| Year |
Citation |
Score |
| 2020 |
Blaschke CRK, Black AP, Mehta AS, Angel PM, Drake RR. Rapid N-Glycan Profiling of Serum and Plasma by a Novel Slide-Based Imaging Mass Spectrometry Workflow. Journal of the American Society For Mass Spectrometry. PMID 32809822 DOI: 10.1021/Jasms.0C00213 |
0.332 |
|
| 2020 |
Murali P, Johnson BP, Lu Z, Climer L, Scott DA, Foulquier F, Oprea-Ilies G, Lupashin V, Drake RR, Abbott KL. Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma. Oncotarget. 11: 2747-2762. PMID 32733646 DOI: 10.18632/Oncotarget.27668 |
0.331 |
|
| 2020 |
Angel PM, Spruill L, Jefferson M, Bethard JR, Ball LE, Hughes-Halbert C, Drake RR. Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry. The Prostate. PMID 32687633 DOI: 10.1002/Pros.24031 |
0.382 |
|
| 2020 |
West CA, Liang H, Drake RR, Mehta AS. A New Enzymatic Approach to Distinguish Fucosylation Isomers of N-linked Glycans in Tissues Using MALDI Imaging Mass Spectrometry. Journal of Proteome Research. PMID 32441096 DOI: 10.1021/Acs.Jproteome.0C00024 |
0.359 |
|
| 2020 |
Jefferson M, Drake RR, Lilly M, Savage SJ, Tucker Price S, Hughes Halbert C. Co-morbidities in a Retrospective Cohort of Prostate Cancer Patients. Ethnicity & Disease. 30: 185-192. PMID 32269460 DOI: 10.18865/Ed.30.S1.185 |
0.304 |
|
| 2020 |
Drake RR, David F, Miller C, Jefferson M, Spruill L, Liss M, Weaver B, Angel PM, Leach R, Hughes-Halbert C. Abstract C032: Distinguishing lethal from indolent prostate cancer using N-glycan imaging mass spectrometry in a racial tissue microarray cohort Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-C032 |
0.38 |
|
| 2019 |
Drake RR, McDowell C, West C, David F, Powers TW, Nowling T, Bruner E, Mehta AS, Angel PM, Marlow LA, Tun HW, Copland JA. Defining the Human Kidney N-Glycome in Normal and Cancer Tissues Using MALDI Imaging Mass Spectrometry. Journal of Mass Spectrometry : Jms. e4490. PMID 31860772 DOI: 10.1002/Jms.4490 |
0.39 |
|
| 2019 |
Black AP, Angel PM, Drake RR, Mehta AS. Antibody Panel Based N-Glycan Imaging for N-Glycoprotein Biomarker Discovery. Current Protocols in Protein Science. 98: e99. PMID 31721442 DOI: 10.1002/Cpps.99 |
0.329 |
|
| 2019 |
Angel PM, Bruner E, Bethard J, Clift CL, Ball L, Drake RR, Feghali-Bostwick C. Extracellular Matrix Alterations in Low Grade Lung Adenocarcinoma Compared to Normal Lung Tissue by Imaging Mass Spectrometry. Journal of Mass Spectrometry : Jms. PMID 31654589 DOI: 10.1002/Jms.4450 |
0.342 |
|
| 2019 |
Angel PM, Saunders J, Clift CL, White-Gilbertson S, Voelkel-Johnson C, Yeh E, Mehta A, Drake RR. A Rapid Array-Based Approach to -Glycan Profiling of Cultured Cells. Journal of Proteome Research. PMID 31535553 DOI: 10.1021/Acs.Jproteome.9B00303 |
0.308 |
|
| 2019 |
Drake RR, Angel PM, Wu J, Pachynski RK, Ippolito JE. How else can we approach prostate cancer biomarker discovery? Expert Review of Molecular Diagnostics. PMID 31498690 DOI: 10.1080/14737159.2019.1665507 |
0.316 |
|
| 2019 |
Scott DA, Drake RR. Glycosylation and its implications in breast cancer. Expert Review of Proteomics. PMID 31314995 DOI: 10.1080/14789450.2019.1645604 |
0.312 |
|
| 2019 |
Black A, Liang H, West CA, Wang M, Herrera H, Haab B, Angel PM, Drake RR, Mehta A. A Novel Mass Spectrometry Platform for Multiplexed N-glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-glycan Imaging. Analytical Chemistry. PMID 31177770 DOI: 10.1021/Acs.Analchem.9B01445 |
0.319 |
|
| 2019 |
Herrera H, Dilday T, Uber A, Scott D, Zambrano JN, Wang M, Angel PM, Mehta AS, Drake RR, Hill EG, Yeh ES. Core-Fucosylated Tetra-Antennary -Glycan Containing A Single -Acetyllactosamine Branch Is Associated with Poor Survival Outcome in Breast Cancer. International Journal of Molecular Sciences. 20. PMID 31126011 DOI: 10.3390/Ijms20102528 |
0.349 |
|
| 2019 |
Scott DA, Norris-Caneda K, Spruill L, Bruner E, Kono Y, Angel PM, Mehta AS, Drake RR. Specific N-Linked Glycosylation Patterns in Areas of Necrosis in Tumor Tissues. International Journal of Mass Spectrometry. 437: 69-76. PMID 31031563 DOI: 10.1016/J.Ijms.2018.01.002 |
0.401 |
|
| 2018 |
Scott DA, Casadonte R, Cardinali B, Spruill L, Mehta AS, Carli F, Simone N, Kriegsmann M, Mastro LD, Kriegsmann J, Drake RR. Increases in Tumor N-glycan Polylactosamines Associated with Advanced HER2 Positive and Triple Negative Breast Cancer Tissues. Proteomics. Clinical Applications. e1800014. PMID 30592377 DOI: 10.1002/Prca.201800014 |
0.378 |
|
| 2018 |
Drake RR, West CA, Mehta AS, Angel PM. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Tissues. Advances in Experimental Medicine and Biology. 1104: 59-76. PMID 30484244 DOI: 10.1007/978-981-13-2158-0_4 |
0.365 |
|
| 2018 |
Mercer KE, Pulliam CF, Hennings L, Cleves MA, Jones EE, Drake RR, Ronis MJJ. Diet Supplementation with Soy Protein Isolate, but Not the Isoflavone Genistein, Protects Against Alcohol-Induced Tumor Progression in DEN-Treated Male Mice. Advances in Experimental Medicine and Biology. 1032: 115-126. PMID 30362095 DOI: 10.1007/978-3-319-98788-0_9 |
0.622 |
|
| 2018 |
Angel PM, Schwamborn K, Comte-Walters S, Clift C, Ball LE, Mehta AS, Drake RR. Extracellular Matrix Imaging of Breast Tissue Pathologies by MALDI Imaging Mass Spectrometry. Proteomics. Clinical Applications. e1700152. PMID 30251340 DOI: 10.1002/Prca.201700152 |
0.33 |
|
| 2018 |
Angel PM, Norris-Caneda K, Drake RR. In Situ Imaging of Tryptic Peptides by MALDI Imaging Mass Spectrometry Using Fresh-Frozen or Formalin-Fixed, Paraffin-Embedded Tissue. Current Protocols in Protein Science. e65. PMID 30114342 DOI: 10.1002/Cpps.65 |
0.322 |
|
| 2018 |
West CA, Wang M, Herrera H, Liang H, Black A, Angel PM, Drake RR, Mehta AS. N-linked glycan branching and fucosylation are increased directly in hepatocellular carcinoma tissue as determined through in situ glycan imaging. Journal of Proteome Research. PMID 30110170 DOI: 10.1021/Acs.Jproteome.8B00323 |
0.338 |
|
| 2018 |
Drake RR, Powers TW, Norris-Caneda K, Mehta AS, Angel PM. In Situ Imaging of N-Glycans by MALDI Imaging Mass Spectrometry of Fresh or Formalin-Fixed Paraffin-Embedded Tissue. Current Protocols in Protein Science. e68. PMID 30074304 DOI: 10.1002/Cpps.68 |
0.353 |
|
| 2018 |
Liu Y, Barnett D, Staal B, Huang Y, Partyka K, Zeh H, Singhi A, Drake RR, Brand RE, Haab BB. Abstract 4624: The sTRA glycan is complementary to CA19-9 as a serologic biomarker of pancreatic cancer Cancer Research. 78: 4624-4624. DOI: 10.1158/1538-7445.Am2018-4624 |
0.311 |
|
| 2018 |
Barnett D, Liu Y, Gao C, Wisniewski L, Partyka K, Barry A, Hostetter G, Singhi A, Brand RE, Drake RR, Haab BB. Abstract 3688: A novel biomarker for pancreatic cancer, sTRA, and CA19-9 define separate subpopulations of PDAC cells with distinctions in behavior and molecular characteristics Cancer Research. 78: 3688-3688. DOI: 10.1158/1538-7445.Am2018-3688 |
0.353 |
|
| 2018 |
Angel P, Brockbank KG, Drake RR. Molecular mapping of tissue histological features by imaging mass spectrometry as a tool for tissue and organ transplant studies Cryobiology. 81: 224-225. DOI: 10.1016/J.Cryobiol.2017.12.054 |
0.301 |
|
| 2017 |
Angel PM, Comte-Walters S, Ball LE, Talbot K, Mehta A, Brockbank KGM, Drake RR. Mapping Extracellular Matrix Proteins in Formalin-Fixed, Paraffin-embedded Tissues by MALDI Imaging Mass Spectrometry. Journal of Proteome Research. PMID 29161047 DOI: 10.1021/Acs.Jproteome.7B00713 |
0.341 |
|
| 2017 |
Angel PM, Mehta A, Norris-Caneda K, Drake RR. MALDI Imaging Mass Spectrometry of N-glycans and Tryptic Peptides from the Same Formalin-Fixed, Paraffin-Embedded Tissue Section. Methods in Molecular Biology (Clifton, N.J.). PMID 29058228 DOI: 10.1007/7651_2017_81 |
0.334 |
|
| 2017 |
Barnett D, Liu Y, Partyka K, Huang Y, Tang H, Hostetter G, Brand RE, Singhi AD, Drake RR, Haab BB. The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. Scientific Reports. 7: 4020. PMID 28642461 DOI: 10.1038/S41598-017-04164-Z |
0.36 |
|
| 2017 |
Angel PM, Baldwin HS, Gottlieb D, Su YR, Mayer JE, Bichell D, Drake RR. Advances in MALDI Imaging Mass Spectrometry of Proteins in Cardiac Tissue, Including the Heart Valve. Biochimica Et Biophysica Acta. PMID 28341601 DOI: 10.1016/J.Bbapap.2017.03.009 |
0.336 |
|
| 2017 |
Drake RR, Powers TW, Jones EE, Bruner E, Mehta AS, Angel PM. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues. Advances in Cancer Research. 134: 85-116. PMID 28110657 DOI: 10.1016/Bs.Acr.2016.11.009 |
0.415 |
|
| 2017 |
McDonnell LA, Angel PM, Lou S, Drake RR. Mass Spectrometry Imaging in Cancer Research: Future Perspectives. Advances in Cancer Research. 134: 283-290. PMID 28110655 DOI: 10.1016/Bs.Acr.2016.11.010 |
0.373 |
|
| 2017 |
Scott D, Angel P, Xu H, Drake R, Yeh E. Abstract P6-07-30: Identifying novel glycosylation markers in Her2+ breast cancer using MALDI mass spectrometry Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P6-07-30 |
0.365 |
|
| 2017 |
Claude E, Angel PM, Drake RR, Olivos H, Langridge JI. Abstract 4642: Ion mobility separation of N-Glycans directly from ffpe colon cancer tissue section in a MALDI imaging experiment Cancer Research. 77: 4642-4642. DOI: 10.1158/1538-7445.Am2017-4642 |
0.384 |
|
| 2017 |
Drake RR, Talbot K, Norris-Caneda K, Bruner E, Angel PM. Abstract 202: Comprehensive spatial mapping by MALDI imaging mass spectrometry of the N-glycan tissue glycome and database generation for eighteen tumor types Cancer Research. 77: 202-202. DOI: 10.1158/1538-7445.Am2017-202 |
0.335 |
|
| 2017 |
Barnett D, Liu Y, Partyka K, Hostetter G, Zeh H, Singhi AD, Huang Y, Drake RR, Brand RE, Haab BB. Abstract 1754: A new glycan biomarker for pancreatic cancer complements CA19-9 and identifies a distinct subpopulation of cancer cells Cancer Research. 77: 1754-1754. DOI: 10.1158/1538-7445.Am2017-1754 |
0.316 |
|
| 2016 |
Shao S, Neely BA, Kao TC, Eckhaus J, Bourgeois J, Brooks J, Jones EE, Drake RR, Zhu K. Proteomic profiling of serial pre-diagnostic serum samples for early detection of colon cancer in the U.S. military. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28003179 DOI: 10.1158/1055-9965.Epi-16-0732 |
0.322 |
|
| 2016 |
Reatini BS, Ensink E, Liau B, Sinha JY, Powers TW, Partyka K, Bern M, Brand RE, Rudd PM, Kletter D, Drake RR, Haab BB. Characterizing Protein Glycosylation through On-Chip Glycan Modification and Probing. Analytical Chemistry. PMID 27809484 DOI: 10.1021/Acs.Analchem.6B02998 |
0.345 |
|
| 2016 |
Heijs B, Holst S, Briaire-de Bruijn IH, van Pelt GW, de Ru AH, van Veelen PA, Drake RR, Mehta AS, Mesker WE, Tollenaar RA, Bovee JV, Wuhrer M, McDonnell LA. Multimodal Mass Spectrometry Imaging of N-glycans and Proteins from the Same Tissue Section. Analytical Chemistry. PMID 27373711 DOI: 10.1021/Acs.Analchem.6B01739 |
0.374 |
|
| 2016 |
Kim Y, Jeon J, Mejia S, Yao CQ, Ignatchenko V, Nyalwidhe JO, Gramolini AO, Lance RS, Troyer DA, Drake RR, Boutros PC, Semmes OJ, Kislinger T. Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer. Nature Communications. 7: 11906. PMID 27350604 DOI: 10.1038/Ncomms11906 |
0.35 |
|
| 2016 |
Holst S, Heijs B, de Haan N, van Zeijl RJ, Briaire-de Bruijn IH, van Pelt GW, Mehta AS, Angel PM, Mesker WE, Tollenaar RA, Drake RR, Bovee JV, McDonnell LA, Wuhrer M. Linkage-specific in-situ sialic acid derivatization for N-glycan mass spectrometry imaging of FFPE tissues. Analytical Chemistry. PMID 27145236 DOI: 10.1021/Acs.Analchem.6B00819 |
0.38 |
|
| 2016 |
Neely BA, Wilkins CE, Marlow LA, Malyarenko D, Kim Y, Ignatchenko A, Sasinowska H, Sasinowski M, Nyalwidhe JO, Kislinger T, Copland JA, Drake RR. Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma. Plos One. 11: e0154074. PMID 27128972 DOI: 10.1371/Journal.Pone.0154074 |
0.346 |
|
| 2016 |
Mercer KE, Pulliam C, Hennings L, Lai K, Cleves M, Jones E, Drake RR, Ronis M. Soy protein isolate protects against ethanol-mediated tumor progression in diethylnitrosamine-treated male mice. Cancer Prevention Research (Philadelphia, Pa.). PMID 27006377 DOI: 10.1158/1940-6207.Capr-15-0417 |
0.627 |
|
| 2015 |
Jones EE, Gao P, Smith CD, Norris JS, Drake RR. Tissue biomarkers of drug efficacy: case studies using a MALDI-MSI workflow. Bioanalysis. 7: 2611-9. PMID 26505686 DOI: 10.4155/Bio.15.174 |
0.319 |
|
| 2015 |
Yang L, Dutta SM, Troyer DA, Lin JB, Lance RA, Nyalwidhe JO, Drake RR, Semmes OJ. Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer. Oncotarget. PMID 26497208 DOI: 10.18632/Oncotarget.6193 |
0.385 |
|
| 2015 |
Venant H, Rahmaniyan M, Jones EE, Lu P, Lilly MB, Garrett-Mayer E, Drake RR, Kraveka JM, Smith CD, Voelkel-Johnson C. The sphingosine kinase 2 inhibitor ABC294640 reduces the growth of prostate cancer cells and results in accumulation of dihydroceramides in vitro and in vivo. Molecular Cancer Therapeutics. PMID 26494858 DOI: 10.1158/1535-7163.Mct-15-0279 |
0.357 |
|
| 2015 |
Drake RR, Jones EE, Powers TW, Nyalwidhe JO. Altered glycosylation in prostate cancer. Advances in Cancer Research. 126: 345-82. PMID 25727153 DOI: 10.1016/Bs.Acr.2014.12.001 |
0.334 |
|
| 2015 |
Drake RR. Glycosylation and cancer: moving glycomics to the forefront. Advances in Cancer Research. 126: 1-10. PMID 25727144 DOI: 10.1016/Bs.Acr.2014.12.002 |
0.339 |
|
| 2015 |
Drake RR, Powers TW, Neely BA. Abstract 540: A MALDI imaging mass spectrometry approach using tissue microarrays to identify an N-glycan biomarker panel for pancreatic cancers Cancer Research. 75: 540-540. DOI: 10.1158/1538-7445.Am2015-540 |
0.403 |
|
| 2015 |
Lewis H, Hasegawa T, Glavich G, Lance R, Semmes OJ, Beydoun H, Drake R, Esquela-Kerscher A. Abstract 3086: From profiling to function: A role for microRNA miR-888 in promoting prostate cancer progression Cancer Research. 75: 3086-3086. DOI: 10.1158/1538-7445.Am2015-3086 |
0.329 |
|
| 2014 |
Powers TW, Neely BA, Shao Y, Tang H, Troyer DA, Mehta AS, Haab BB, Drake RR. MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays. Plos One. 9: e106255. PMID 25184632 DOI: 10.1371/Journal.Pone.0106255 |
0.382 |
|
| 2014 |
Jones EE, Dworski S, Canals D, Casas J, Fabrias G, Schoenling D, Levade T, Denlinger C, Hannun YA, Medin JA, Drake RR. On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Analytical Chemistry. 86: 8303-11. PMID 25072097 DOI: 10.1021/Ac501937D |
0.373 |
|
| 2014 |
Von Roemeling CA, Marlow LA, Radisky DC, Rohl A, Larsen HE, Wei J, Sasinowska H, Zhu H, Drake R, Sasinowski M, Tun HW, Copland JA. Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration. Oncotarget. 5: 5320-34. PMID 24979721 DOI: 10.18632/Oncotarget.2097 |
0.32 |
|
| 2014 |
Drake RR, Kislinger T. The proteomics of prostate cancer exosomes. Expert Review of Proteomics. 11: 167-77. PMID 24564711 DOI: 10.1586/14789450.2014.890894 |
0.345 |
|
| 2014 |
Jones EE, Powers TW, Neely BA, Cazares LH, Troyer DA, Parker AS, Drake RR. MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics. 14: 924-35. PMID 24497498 DOI: 10.1002/Pmic.201300434 |
0.377 |
|
| 2014 |
Jones EE, Dworski S, Kamani M, Medin JA, Drake RR. On-tissue profiling of ceramides and other sphingolipids in lysosomal disorders using high resolution MALDI-imaging mass spectrometry Molecular Genetics and Metabolism. 111: S56-S57. DOI: 10.1016/J.Ymgme.2013.12.123 |
0.312 |
|
| 2013 |
Cheng JC, Bai A, Beckham TH, Marrison ST, Yount CL, Young K, Lu P, Bartlett AM, Wu BX, Keane BJ, Armeson KE, Marshall DT, Keane TE, Smith MT, Jones EE, ... Drake RR, et al. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. The Journal of Clinical Investigation. 123: 4344-58. PMID 24091326 DOI: 10.1172/Jci64791 |
0.34 |
|
| 2013 |
Powers TW, Jones EE, Betesh LR, Romano PR, Gao P, Copland JA, Mehta AS, Drake RR. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Analytical Chemistry. 85: 9799-806. PMID 24050758 DOI: 10.1021/Ac402108X |
0.386 |
|
| 2013 |
Nyalwidhe JO, Betesh LR, Powers TW, Jones EE, White KY, Burch TC, Brooks J, Watson MT, Lance RS, Troyer DA, Semmes OJ, Mehta A, Drake RR. Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics. Clinical Applications. 7: 677-89. PMID 23775902 DOI: 10.1002/Prca.201200134 |
0.32 |
|
| 2013 |
Leymarie N, Griffin PJ, Jonscher K, Kolarich D, Orlando R, McComb M, Zaia J, Aguilan J, Alley WR, Altmann F, Ball LE, Basumallick L, Bazemore-Walker CR, Behnken H, Blank MA, ... ... Drake RR, et al. Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Molecular & Cellular Proteomics : McP. 12: 2935-51. PMID 23764502 DOI: 10.1074/Mcp.M113.030643 |
0.402 |
|
| 2013 |
Principe S, Jones EE, Kim Y, Sinha A, Nyalwidhe JO, Brooks J, Semmes OJ, Troyer DA, Lance RS, Kislinger T, Drake RR. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. Proteomics. 13: 1667-71. PMID 23533145 DOI: 10.1002/Pmic.201200561 |
0.331 |
|
| 2013 |
Beckham TH, Lu P, Jones EE, Marrison T, Lewis CS, Cheng JC, Ramshesh VK, Beeson G, Beeson CC, Drake RR, Bielawska A, Bielawski J, Szulc ZM, Ogretmen B, Norris JS, et al. LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. The Journal of Pharmacology and Experimental Therapeutics. 344: 167-78. PMID 23086228 DOI: 10.1124/Jpet.112.199216 |
0.32 |
|
| 2013 |
Drake RR, Powers T, Jones E, Lance RS, Mehta AS, Troyer DA. Abstract 1523: MALDI mass spectrometry imaging for on-tissue spatial profiling of tumor-specific N-linked glycans and lipids in renal carcinomas. Cancer Research. 73: 1523-1523. DOI: 10.1158/1538-7445.Am2013-1523 |
0.388 |
|
| 2013 |
Cardinali B, Powers T, Carli F, Drake R, Del Mastro L. Breast Cancer Heterogeneity: the Potential Role of Maldi Imaging Mass Spectrometry in Subtyping Annals of Oncology. 24: iii25. DOI: 10.1093/Annonc/Mdt083.12 |
0.322 |
|
| 2012 |
Kim Y, Ignatchenko V, Yao CQ, Kalatskaya I, Nyalwidhe JO, Lance RS, Gramolini AO, Troyer DA, Stein LD, Boutros PC, Medin JA, Semmes OJ, Drake RR, Kislinger T. Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Molecular & Cellular Proteomics : McP. 11: 1870-84. PMID 22986220 DOI: 10.1074/Mcp.M112.017889 |
0.359 |
|
| 2009 |
Cazares LH, Troyer D, Mendrinos S, Lance RA, Nyalwidhe JO, Beydoun HA, Clements MA, Drake RR, Semmes OJ. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5541-51. PMID 19690195 DOI: 10.1158/1078-0432.Ccr-08-2892 |
0.38 |
|
| 2009 |
Karbassi ID, Nyalwidhe JO, Wilkins CE, Cazares LH, Lance RS, Semmes OJ, Drake RR. Proteomic expression profiling and identification of serum proteins using immobilized trypsin beads with MALDI-TOF/TOF. Journal of Proteome Research. 8: 4182-92. PMID 19603828 DOI: 10.1021/Pr800836C |
0.323 |
|
| 2009 |
White KY, Rodemich L, Nyalwidhe JO, Comunale MA, Clements MA, Lance RS, Schellhammer PF, Mehta AS, Semmes OJ, Drake RR. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids. Journal of Proteome Research. 8: 620-30. PMID 19128049 DOI: 10.1021/Pr8007545 |
0.322 |
|
| 2003 |
Drake RR, Manne U, Adam B, Ahn C, Cazares L, Semmes O, Bigbee WL, Grizzle WE, Johnson DA. SELDI-TOF-MS profiling of serum for early detection of colorectal cancer Gastroenterology. 124: A650. DOI: 10.1016/S0016-5085(03)83293-6 |
0.307 |
|
| 2002 |
Mercer KE, Ahn CE, Coke A, Compadre CM, Drake RR. Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies. Protein Engineering. 15: 903-11. PMID 12538910 DOI: 10.1093/Protein/15.11.903 |
0.606 |
|
| 2000 |
Drake RR, Pitlyk K, McMasters RA, Mercer KE, Young H, Moyer MP. Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 515-23. PMID 11082325 DOI: 10.1006/Mthe.2000.0192 |
0.582 |
|
| Show low-probability matches. |